AIRA Matrix, a pioneer in AI-driven quality control (QC) solutions, has partnered with Gestalt, a leader in IMS and digital pathology, to integrate AIRAQC into Gestalt’s PathFlow. This collaboration enhances diagnostic accuracy, efficiency, and quality control in pathology laboratories worldwide.
“This partnership expands AIRAQC’s reach, delivering transformative AI capabilities to pathology labs,” says Marco Comianos, Head of Commercial Operations – US, AIRA Matrix.
Benefits of the AIRA Matrix-Gestalt Partnership
1. AI-Powered Quality Control (QC) for Pathology
- Automated QC analysis enhances accuracy and reduces errors.
- Enables faster, more precise pathology workflows.
2. Seamless Integration with Gestalt’s PathFlow
- Provides pathologists with AI-enhanced decision-making tools.
- Ensures a smoother workflow with real-time AI insights.
3. Optimized Diagnostic Efficiency
- Reduces manual QC workload, allowing pathologists to focus on complex cases.
- Improves laboratory throughput and reporting speed.
4. Commitment to Advancing Pathology Innovation
“This partnership leverages technology to meet evolving healthcare needs,” says Lisa-Jean Clifford, COO & Chief Strategy Officer at Gestalt. “Our shared goal is to empower labs with state-of-the-art tools that enhance diagnostic quality and accuracy.”
By integrating AIRAQC with PathFlow, AIRA Matrix and Gestalt are setting a new standard for AI-driven pathology workflows. This collaboration ensures laboratories worldwide gain access to advanced AI solutions, driving efficiency, precision, and innovation in diagnostic decision-making
